Detalles de la búsqueda
1.
Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer.
Br J Cancer
; 109(2): 325-31, 2013 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23807167
2.
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?
Ann Oncol
; 23(11): 2943-2947, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22771826
3.
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study.
Br J Cancer
; 103(3): 332-9, 2010 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-20628389
4.
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.
Br J Cancer
; 102(4): 678-84, 2010 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20104229
5.
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC).
Ann Oncol
; 21(1): 109-13, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19608618
6.
Optical excitation of a forbidden magnetic resonance mode in a doped lutetium-iron-garnet film via the inverse Faraday effect.
Phys Rev Lett
; 105(10): 107402, 2010 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20867547
7.
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.
Ann Oncol
; 20(1): 27-33, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18695026
8.
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours.
Br J Cancer
; 98(5): 894-9, 2008 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-18319713
Resultados
1 -
8
de 8
1
Próxima >
>>